Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2022 Jul;61(7):903-904.
doi: 10.1111/ijd.16262. Epub 2022 May 14.

Marie Antoinette syndrome following COVID-19 vaccination

Affiliations
Comment

Marie Antoinette syndrome following COVID-19 vaccination

Maria E Baffa et al. Int J Dermatol. 2022 Jul.
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
Three months before the occurrence of AA, the patient did not show any hair alteration (a); 4 days after COVID‐19 vaccination, the patient developed prominent hair loss in the central area of the scalp and sudden graying of the hair (b, c) together with nail pitting (d). Trichoscopic examination showed yellow dots, newly growing hair, and exclamation mark hairs (e). After 6 weeks of therapy, regrowth was almost complete (f)

Comment on

References

    1. May Lee M, Bertolani M, Pierobon E, et al. Alopecia areata following COVID‐19 vaccination: vaccine‐induced autoimmunity? Int J Dermatol 2022;61:634–635. - PubMed
    1. Scollan ME, Breneman A, Kinariwalla N et al. Alopecia areata after SARS‐CoV‐2 vaccination. JAAD Case Rep 2022;20:1–5 - PMC - PubMed
    1. Essam R, Ehab R, Al‐Razzaz R, et al. Alopecia areata after ChAdOx1 nCoV‐19 vaccine (Oxford/AstraZeneca): a potential triggering factor? J Cosmet Dermatol 2021; 20: 3727–3729. - PMC - PubMed
    1. Navarini AA, Nobbe S, Trüeb RM. Marie Antoinette syndrome. Arch Dermatol 2009; 145: 656. - PubMed
    1. Rossi A, Magri F, Michelini S, et al. Recurrence of alopecia areata after covid‐19 vaccination: A report of three cases in Italy. J Cosmet Dermatol 2021; 20: 3753–3757. - PubMed

Substances